,Response,Percentage of men enrolled in TT prescription
0,Hypolipidemics,37%
1,SSRIs,20.7%
2,Ace inhibitors,18.1%
3,NSAIDs,16.3%
4,Beta blockers,15.5%
5,Anti-diabetes drugs,15.2%
6,Other cardiac drugs,13.8%
7,Corticosteroids,12.7%
8,Calcium channel blockers,11.7%
9,Diuretics,10.4%
10,Insulin,3.9%
11,Antiplatelets,3.4%
12,Anti-hypertensive NOS,3.2%
13,Anticoagulant,2.8%
14,Vasodialators,2%
